Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefewel S Injection
Cefewel S Injection offers a broad-spectrum antibiotic solution for managing severe bacterial infections. With Cefepime 3g and Sulbactam 1g, this powerful combination delivers reliable protection against resistant pathogens, ensuring better treatment outcomes in hospitalized patients.
Uses of Cefewel S Injection
Treatment of severe intra-abdominal infections
Effective for complicated urinary tract infections (UTIs)
Management of pneumonia, including hospital-acquired infections
Useful in skin and soft tissue infections caused by resistant bacteria
Provides a reliable option for febrile neutropenia in immunocompromised patients
Benefits of Cefewel S Injection
Broad-spectrum activity, including beta-lactamase-producing strains
Enhanced efficacy against resistant pathogens
Rapid bacterial clearance, improving patient recovery times
Clinically proven safety and effectiveness in severe infections
Offers a trusted treatment option in critical-care settings
Mechanism of Action of Cefewel S Injection
Cefepime disrupts bacterial cell wall synthesis, killing the bacteria.
Sulbactam inhibits beta-lactamase enzymes, protecting Cefepime from inactivation.
Together, they provide comprehensive bacterial coverage, even in the presence of resistance.